Tom Wilemon

Lovly to chair foundation’s scientific leadership board

Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation’s Scientific Leadership Board (SLB).

VUMC researchers selected for inaugural FDA-AACR fellowship

Henry Henderson III, PhD, and Justin Lo, MD, PhD, are members of the 2020-2021 inaugural class of FDA-AACR Oncology Educational Fellows.

Park named director of Hematology and Oncology at VICC

After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, Donna S. Hall Professor of Breast Cancer Research at Vanderbilt University Medical Center, has been named director of the Division of Hematology and Oncology.

By Tom Wilemon

October 21, 2020

‘Black in Cancer’ promotes diversity in research

Black In Cancer, an initiative cofounded by Henry Henderson III, PhD, a postdoctoral researcher at Vanderbilt-Ingram Cancer Center, is making an impact just two months after its inception.

By Tom Wilemon

October 15, 2020

Initiative seeks to extract cancer phenotypes from electronic health records

The National Cancer Institute (NCI) has funded the development of interactive visual tools that will allow researchers to extract cancer phenotypes from electronic medical records.

By Tom Wilemon

A childhood role model helped inspire Portia Thomas to pursue a career in medicine and research.

October 1, 2020

Diversity role model inspires career path

Portia Thomas grew up in Doerun, Georgia, a small, rural city named by pioneer hunters as a place with “a perfect doe run,” where the population has hovered around 800 people for the past 30 years. A childhood impression lifted her aspirations beyond her hometown and inspired her to pursue a career as a physician-scientist.